These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1411 related items for PubMed ID: 19232683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C.
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [Abstract] [Full Text] [Related]

  • 5. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B, Eraslan S, Eroğlu S, Kesim BE, Ulutin T, Yalçiner A, Laleli YR, Gözükirmizi N.
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G, Valverde S.
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [Abstract] [Full Text] [Related]

  • 8. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D, Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D, Zadro R, Honović L, Banfić L, Stavljenić Rukavina A.
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [Abstract] [Full Text] [Related]

  • 10. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E, Lacut K, Le Gal G, Couturaud F, Abalain JH, Mercier B, Mottier D, EDITH (Etude des Déterminants/Interaction de la THrombose veineuse) Collaborative Study Group.
    Thromb Res; 2007 Aug; 120(2):207-14. PubMed ID: 17126889
    [Abstract] [Full Text] [Related]

  • 11. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S, Klinke S, von Depka Prondzinski M, Kreuz W, Ganser A, Scharrer I.
    Dtsch Med Wochenschr; 1999 Jun 25; 124(25-26):783-7. PubMed ID: 10414227
    [Abstract] [Full Text] [Related]

  • 12. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.
    Andreescu AC, Cushman M, Rosendaal FR.
    Thromb Haemost; 2002 Jan 25; 87(1):47-51. PubMed ID: 11858188
    [Abstract] [Full Text] [Related]

  • 13. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.
    Haematologica; 2008 May 25; 93(5):729-34. PubMed ID: 18387978
    [Abstract] [Full Text] [Related]

  • 14. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
    Torres JD, Cardona H, Alvarez L, Cardona-Maya W, Castañeda SA, Quintero-Rivera F, Cadavid A, Bedoya G, Tobón L.
    Am J Hematol; 2006 Dec 25; 81(12):933-7. PubMed ID: 16917913
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F.
    Am J Hematol; 2002 Sep 25; 71(1):1-6. PubMed ID: 12221665
    [Abstract] [Full Text] [Related]

  • 18. Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease.
    Guédon C, Le Cam-Duchez V, Lalaude O, Ménard JF, Lerebours E, Borg JY.
    Am J Gastroenterol; 2001 May 25; 96(5):1448-54. PubMed ID: 11374681
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY.
    Am J Hematol; 2002 Dec 25; 71(4):300-5. PubMed ID: 12447960
    [Abstract] [Full Text] [Related]

  • 20. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L, Nguyen P, Hezard N, Musharrafieh U, Almawi WY, Mahjoub T.
    Exp Mol Pathol; 2007 Dec 25; 83(3):480-3. PubMed ID: 17555744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.